Package 63323-403-10

{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "84385df0-4793-47d2-8e49-5c84668a0ba3", "openfda": {"upc": ["0363323403010", "0363323403041"], "unii": ["7VLR55452Z"], "rxcui": ["1670195", "1670200"], "spl_set_id": ["b60c9c82-e5c7-4e05-98c7-5bbba4af04b2"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 TRAY (63323-403-02)  / 2 mL in 1 VIAL (63323-403-01)", "package_ndc": "63323-403-02", "marketing_start_date": "20091214"}, {"sample": false, "description": "10 VIAL in 1 TRAY (63323-403-10)  / 10 mL in 1 VIAL (63323-403-04)", "package_ndc": "63323-403-10", "marketing_start_date": "20091214"}], "brand_name": "Fosphenytoin", "product_id": "63323-403_84385df0-4793-47d2-8e49-5c84668a0ba3", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "63323-403", "generic_name": "FOSPHENYTOIN SODIUM", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fosphenytoin", "active_ingredients": [{"name": "FOSPHENYTOIN SODIUM", "strength": "50 mg/mL"}], "application_number": "ANDA078052", "marketing_category": "ANDA", "marketing_start_date": "20091214", "listing_expiration_date": "20261231"}